These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7729895)

  • 21. Recombinant OprF-OprI as a vaccine against Pseudomonas aeruginosa infections.
    Baumann U; Mansouri E; von Specht BU
    Vaccine; 2004 Feb; 22(7):840-7. PubMed ID: 15040936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and immunogenicity of an intranasal Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers.
    Larbig M; Mansouri E; Freihorst J; Tümmler B; Köhler G; Domdey H; Knapp B; Hungerer KD; Hundt E; Gabelsberger J; von Specht BU
    Vaccine; 2001 Mar; 19(17-19):2291-7. PubMed ID: 11257350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study on Construction of Recombinant Bb-pGEX-
    Liu X; Li WG; Luo GX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):13-17. PubMed ID: 29737082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenic efficacy of differently produced recombinant vaccines candidates against Pseudomonas aeruginosa infections.
    von Specht BU; Gabelsberger J; Knapp B; Hundt E; Schmidt-Pilger H; Bauernsachs S; Lenz U; Domdey H
    J Biotechnol; 2000 Sep; 83(1-2):3-12. PubMed ID: 11000453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A recombinant hybrid outer membrane protein for vaccination against Pseudomonas aeruginosa.
    Knapp B; Hundt E; Lenz U; Hungerer KD; Gabelsberger J; Domdey H; Mansouri E; Li Y; von Specht BU
    Vaccine; 1999 Mar; 17(13-14):1663-6. PubMed ID: 10194820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunotherapy with IgY Antibodies toward Outer Membrane Protein F Protects Burned Mice against
    Norouzi F; Behrouz B; Ranjbar M; Mousavi Gargari SL
    J Immunol Res; 2020; 2020():7840631. PubMed ID: 32566689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mucosal vaccination with a recombinant OprF-I vaccine of Pseudomonas aeruginosa in healthy volunteers: comparison of a systemic vs. a mucosal booster schedule.
    Göcke K; Baumann U; Hagemann H; Gabelsberger J; Hahn H; Freihorst J; von Specht BU
    FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):167-71. PubMed ID: 12832121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection against P. aeruginosa with an adenovirus vector containing an OprF epitope in the capsid.
    Worgall S; Krause A; Rivara M; Hee KK; Vintayen EV; Hackett NR; Roelvink PW; Bruder JT; Wickham TJ; Kovesdi I; Crystal RG
    J Clin Invest; 2005 May; 115(5):1281-9. PubMed ID: 15841217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant protein composed of Pseudomonas exotoxin A, outer membrane proteins I and F as vaccine against P. aeruginosa infection.
    Chen TY; Shang HF; Chen TL; Lin CP; Hui CF; Hwang J
    Appl Microbiol Biotechnol; 1999 Oct; 52(4):524-33. PubMed ID: 10570800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular characterization of the major outer-membrane protein OprF from plant root-colonizing Pseudomonas fluorescens.
    De Mot R; Schoofs G; Roelandt A; Declerck P; Proost P; Van Damme J; Vanderleyden J
    Microbiology (Reading); 1994 Jun; 140 ( Pt 6)():1377-87. PubMed ID: 7521711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective anti-Pseudomonas aeruginosa humoral and cellular mucosal immunity by AdC7-mediated expression of the P. aeruginosa protein OprF.
    Krause A; Whu WZ; Xu Y; Joh J; Crystal RG; Worgall S
    Vaccine; 2011 Mar; 29(11):2131-9. PubMed ID: 21215829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A DNA vaccine encoding VP22 of herpes simplex virus type I (HSV-1) and OprF confers enhanced protection from Pseudomonas aeruginosa in mice.
    Yu X; Wang Y; Xia Y; Zhang L; Yang Q; Lei J
    Vaccine; 2016 Aug; 34(37):4399-405. PubMed ID: 27449680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Preparation of Pseudomonas aeruginosa recombinant outer-membrane protein F and the study of its antigenic properties].
    Kaloshin AA; Zlygostev SA; Toropchina IuN; Kurbatova EA; Zverev VV; Mikhaĭlova NA
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (5):50-3. PubMed ID: 16279535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chimeric animal and plant viruses expressing epitopes of outer membrane protein F as a combined vaccine against Pseudomonas aeruginosa lung infection.
    Gilleland HE; Gilleland LB; Staczek J; Harty RN; García-Sastre A; Palese P; Brennan FR; Hamilton WD; Bendahmane M; Beachy RN
    FEMS Immunol Med Microbiol; 2000 Apr; 27(4):291-7. PubMed ID: 10727884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective immunity to pseudomonas aeruginosa induced with a capsid-modified adenovirus expressing P. aeruginosa OprF.
    Worgall S; Krause A; Qiu J; Joh J; Hackett NR; Crystal RG
    J Virol; 2007 Dec; 81(24):13801-8. PubMed ID: 17942539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of anti-OprF-OprI immunoglobulin on APACHE II score in a porcine two-hit model of hemorrhagic shock/resuscitation and pseudomonas aeruginosa sepsis.
    Haberstroh J; Gilleland HE; von Specht BU
    Eur Surg Res; 2005; 37(5):265-73. PubMed ID: 16374008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection against Pseudomonas aeruginosa chronic lung infection in mice by genetic immunization against outer membrane protein F (OprF) of P. aeruginosa.
    Price BM; Galloway DR; Baker NR; Gilleland LB; Staczek J; Gilleland HE
    Infect Immun; 2001 May; 69(5):3510-5. PubMed ID: 11292786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of the length of a malarial epitope on its antigenicity and immunogenicity in an epitope presentation system using the Pseudomonas aeruginosa outer membrane protein OprF as the carrier.
    Wong RS; Hancock RE
    FEMS Microbiol Lett; 1996 Jul; 140(2-3):209-14. PubMed ID: 8764483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection against Pseudomonas aeruginosa lung infection in mice by recombinant OprF-pulsed dendritic cell immunization.
    Peluso L; de Luca C; Bozza S; Leonardi A; Giovannini G; Lavorgna A; De Rosa G; Mascolo M; Ortega De Luna L; Catania MR; Romani L; Rossano F
    BMC Microbiol; 2010 Jan; 10():9. PubMed ID: 20070893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of pulmonary antibodies with induced sputum and bronchoalveolar lavage induced by nasal vaccination against Pseudomonas aeruginosa: a clinical phase I/II study.
    Baumann U; Göcke K; Gewecke B; Freihorst J; von Specht BU
    Respir Res; 2007 Aug; 8(1):57. PubMed ID: 17683588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.